Organon (NYSE:OGN) reported quarterly earnings results on February 12, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $0.63, missing the consensus estimate of $0.72 by $0.09 per share. Revenue came in at $1.5B, missing the estimate of $1.5B.
Organon's stock moved following the earnings release. The stock currently trades at $7.39 with a market capitalization of $1.9B.


